Upstreambiotech
Durham, US · 5 known investors
Upstream Biotechnology develops RNA-based seed traits that regulate crop immune defenses at the gene-expression level, activating disease and stress responses only in the affected tissue to limit yield drag. Its SwitchBlade platform targets crops such as corn, soybean, canola, and rice and is developed in collaboration with seed and crop technology companies.
Founders & leadership
GH
George H. GreeneExecutive
XW
Xiao-fang WangNamed on SEC filing
XD
Xinnian DongNamed on SEC filing
Board
KL
Karen LeVertBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$625K disclosed across 1 round · 2025
▶$625KraisedSep 2025 · 3 investors · Other TechnologyRule 506(b)
▶$625KraisedSep 2025 · 3 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Karen LeVertDirector
- Xiao-fang WangDirector
- George H. GreeneExecutive Officer, Director
- Xinnian DongDirector
- Offering amount
- $1.6M
- Amount sold
- $625K
- First sale
- Aug 2025
- Incorporated
- Corporation, North Carolina
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
Upstream Bio17 shared keywordsUpstream Bio is a clinical-stage biotechnology company developing verekitug, an antagonist that targets the TSLP receptor to inhibit pro-inflammatory signaling. Its clinical trials evaluate the treatment of chronic inflammatory respiratory diseases including severe asthma, CRSwNP, and COPD.
Seeking Alpha6 shared keywordsSeeking Alpha is a financial research platform offering stock analysis, market news, investment ideas, and quantitative ratings across asset classes, drawing on a large community of contributing analysts. It serves individual and professional investors seeking research and data-driven insight on stocks and markets.
Companies competing with Upstreambiotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Upstreambiotech do?
- Upstream Biotechnology develops RNA-based seed traits that regulate crop immune defenses at the gene-expression level, activating disease and stress responses only in the affected tissue to limit yield drag. Its SwitchBlade platform targets crops such as corn, soybean, canola, and rice and is developed in collaboration with seed and crop technology companies.
- Who are Upstreambiotech's investors?
- Upstreambiotech's investors include Ag Ventures Alliance, AgLaunch Accelerator, LeVert Ventures, Middleland Capital, Redstick Ventures.
- How much funding has Upstreambiotech raised?
- Upstreambiotech has disclosed $625K raised across 1 round.
- Where is Upstreambiotech headquartered?
- Upstreambiotech is headquartered in Durham, US.